Stock Scorer

Bioceres Crop Solutions Corp. (BIOX)

Bioceres Crop Solutions Corp. reported revenue of 73.7M USD for the quarter ending 31 December 2025, down 25.5% from 98.9M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q4 '25 · ending 31 December 2025 73.7M -25.5%
Gross Profit Q4 '25 · ending 31 December 2025 26.7M -35.8%
Operating Income Q4 '25 · ending 31 December 2025 7.5M +217.6%
Net Income Q4 '25 · ending 31 December 2025 -182.5M -30248.2%
Cost of Revenue Q4 '25 · ending 31 December 2025 47.2M -17.7%
Operating Cash Flow Q4 '25 · ending 31 December 2025 17.4M —
Free Cash Flow Q4 '25 · ending 31 December 2025 17.4M —
Shares Outstanding Q4 '25 · ending 31 December 2025 63.5M +1.0%
EPS Q4 '25 · ending 31 December 2025 -3.78 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-06-30 333.3M-2.2M-58.8M44.3M
20242024-06-30 464.8M45.9M7.3M31.9M
20232023-06-30 419.4M54.2M20.2M-8.8M
20222022-06-30 328.5M39.9M-3.9M-21M
20212021-06-30 206.7M38.4M-3.8M-9M
20202020-06-30 172.4M39.1M4.2M7.7M
20192019-06-30 160.3M32.1M-16.4M27.7M
20182018-06-30 133.5M15.7M-14.3M15.6M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262025-12-3173.7M
Q1 '262025-09-3077.4M
Q4 '252025-06-3074.4M
Q3 '252025-03-3159.6M
Q2 '252024-12-3198.9M
Q1 '252024-09-3092.6M
Q4 '242024-06-30124.3M
Q3 '242024-03-3184M
Q2 '242023-12-31140.3M
Q1 '242023-09-30116.2M
Q4 '232023-06-30105.1M
Q3 '232023-03-3193M
Q2 '232022-12-3194.5M
Q1 '232022-09-30126.8M
Q4 '222022-06-30101.6M
Q3 '222022-03-3168.2M
Q2 '222021-12-3192.3M
Q1 '222021-09-3066.4M
Q2 '212020-12-3148M
Q2 '202019-12-3162.3M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262025-12-3126.7M
Q1 '262025-09-3036.3M
Q4 '252025-06-3025.2M
Q3 '252025-03-3123.8M
Q2 '252024-12-3141.5M
Q1 '252024-09-3037.5M
Q4 '242024-06-3047.4M
Q3 '242024-03-3142.6M
Q2 '242023-12-3151.5M
Q1 '242023-09-3045M
Q4 '232023-06-3040.2M
Q3 '232023-03-3157.5M
Q2 '232022-12-3135.3M
Q1 '232022-09-3051.7M
Q4 '222022-06-3036.5M
Q3 '222022-03-3123.7M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262025-12-317.5M
Q1 '262025-09-307.2M
Q3 '252025-03-31933.2K
Q2 '252024-12-3114.4M
Q1 '252024-09-302.4M
Q4 '242024-06-3010.5M
Q3 '242024-03-3113.2M
Q2 '242023-12-3116.8M
Q1 '242023-09-305.3M
Q4 '232023-06-305.1M
Q3 '232023-03-3129.9M
Q2 '232022-12-312.2M
Q1 '232022-09-3017M
Q4 '222022-06-3010M
Q3 '222022-03-312.1M
Q2 '222021-12-3117.7M
Q1 '222021-09-3010M
Q2 '212020-12-3111.5M
Q2 '202019-12-3119.6M
Q2 '192018-12-3119M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262025-12-31-182.5M
Q1 '262025-09-30-7.4M
Q4 '252025-06-30-51.7M
Q3 '252025-03-31-1.6M
Q2 '252024-12-31605.2K
Q1 '252024-09-30-6.2M
Q4 '242024-06-30-1M
Q3 '242024-03-319.8M
Q2 '242023-12-311.2M
Q1 '242023-09-30-2.7M
Q4 '232023-06-30-2.8M
Q3 '232023-03-3127.5M
Q2 '232022-12-31-8.4M
Q1 '232022-09-303.9M
Q3 '222022-03-31-7M
Q2 '222021-12-315.3M
Q2 '212020-12-311.8M
Q2 '202019-12-3112.6M
Q2 '192018-12-3111.2M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262025-12-3147.2M
Q1 '262025-09-3041.3M
Q4 '252025-06-3049.3M
Q3 '252025-03-3136.7M
Q2 '252024-12-3157.3M
Q1 '252024-09-3055.8M
Q4 '242024-06-3076.6M
Q3 '242024-03-3141.3M
Q2 '242023-12-3188.7M
Q1 '242023-09-3071.6M
Q4 '232023-06-3064.5M
Q3 '232023-03-3136.1M
Q2 '232022-12-3159.1M
Q1 '232022-09-3075.7M
Q4 '222022-06-3069.3M
Q3 '222022-03-3145.8M
Q2 '222021-12-3155.3M
Q1 '222021-09-3037.9M
Q2 '212020-12-3125.1M
Q2 '202019-12-3133M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262025-12-3117.4M
Q1 '262025-09-3014.4M
Q4 '252025-06-3026.8M
Q3 '252025-03-3123.3M
Q2 '252024-12-31-5.4M
Q1 '252024-09-305.2M
Q4 '242024-06-3023.3M
Q3 '242024-03-31-17.4M
Q2 '242023-12-3121.1M
Q1 '242023-09-3014.7M
Q4 '232023-06-30-8.5M
Q3 '232023-03-312.2M
Q2 '232022-12-3141.3M
Q1 '232022-09-30-32.4M
Q3 '222022-03-317.8M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262025-12-3117.4M
Q1 '262025-09-3013.7M
Q4 '252025-06-3026.3M
Q3 '252025-03-3120.9M
Q2 '252024-12-31-6.9M
Q1 '252024-09-303.9M
Q4 '242024-06-3021.2M
Q3 '242024-03-31-19.1M
Q2 '242023-12-3119M
Q1 '242023-09-3010.7M
Q4 '232023-06-30-12.5M
Q3 '232023-03-31-1.3M
Q2 '232022-12-3138.9M
Q1 '232022-09-30-33.8M
Q3 '222022-03-316.6M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262025-12-3163.5M
Q1 '262025-09-3063.4M
Q3 '252025-03-3162.8M
Q2 '252024-12-3163.2M
Q1 '252024-09-3062.9M
Q3 '242024-03-3166.8M
Q2 '242023-12-3163.9M
Q1 '242023-09-3062.8M
Q3 '232023-03-3163.1M
Q2 '232022-12-3161.7M
Q1 '232022-09-3061.7M
Q3 '222022-03-3141.1M
Q2 '222021-12-3142.4M
Q2 '212020-12-3139M
Q2 '202019-12-3136.1M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262025-12-31-3.78
Q1 '242023-09-300.22
Q4 '222022-06-30-0.17